insights_auto
Nega EDIT tushdi 2,63%?
Batafsil oʻrganishchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,66 US$
arrow_downward
-2,63%(-0,045) 1K
20-noy, 14:46:46 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
1,69 US$
Yuqori
1,78 US$
Past
1,64 US$
Bozor kapitali
256,98 mln
Oʻrtacha hajm
2,24 mln
Hajmi
1,33 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,64 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Ochish
1,69 US$
Yuqori
1,78 US$
Past
1,64 US$
Bozor kapitali
256,98 mln
Oʻrtacha hajm
2,24 mln
Hajmi
1,33 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,64 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
GV Wire
·
15 daqiqa oldin
Wall Street Slides on Mounting AI Selloff, S&P 500, Dow Set to Confirm Corrections
WSJ
·
9 soat oldin
S&P 500 Flirts With Correction
Adam Feldman | Substack
·
1 kun oldin
Inside the Federal Litigation of Five S&P 500 Giants
Barron's
·
1 soat oldin
S&P 500’s Tech Sector Crosses Bear Market Threshold
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida
CEO-
Xodimlar soni87
Asos solingannoy 2013
Bosh ofislar-
SektorHealth Care
Soha-
Veb-sayteditasmedicine.com